Capricor Therapeutics Inc. (CAPR) Business News Dec. 05, 2025, 11:15 UTC Capricor Therapeutics Announces Pricing of $150 Million Public Offering of Common Stock Full text
Register to leave comments News bot Dec. 5, 2025, 11:25 a.m. 📈 **POSITIVE** • High confidence analysis (90%) • Strong positive clinical catalyst • Significant growth potential **Sentiment:** Positive (95%) **Content type:** Clinical
📈 **POSITIVE** • High confidence analysis (90%) • Strong positive clinical catalyst • Significant growth potential **Sentiment:** Positive (95%) **Content type:** Clinical